Disclosures for "Safety, Tolerability, and Pharmacokinetics of BHV-2100, a First-in-class TRPM3 Antagonist for Pain and Migraine"
-
Dr. Granit has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Granit has stock in Biohaven. Dr. Granit has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Member with University of Miami. Dr. Granit has a non-compensated relationship as a collaborator in clinical trial design with Cartesian Therapeutics that is relevant to AAN interests or activities.
-
Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
-
Dr. Lucas has nothing to disclose.
-
Eric Ashbrenner has received personal compensation for serving as an employee of Biohaven. Eric Ashbrenner has stock in Biohaven. An immediate family member of Eric Ashbrenner has stock in Biohaven.
-
Mary Donohue has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc.. Mary Donohue has stock in Biohaven Pharmaceuticals, Inc..
-
Patricia Mydlow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biohaven Pharma.
-
Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
-
Joris Vriens has received intellectual property interests from a discovery or technology relating to health care.
-
Thomas Voets has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Emerson has received personal compensation for serving as an employee of Biohaven. Dr. Emerson has received personal compensation for serving as an employee of Pfizer. Dr. Emerson has stock in Biohaven. Dr. Emerson has stock in Pfizer.
-
Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
-
Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.